The Israeli army has launched more than 350 attacks in Syria. According to the news of Syrian Human Rights Watch on December 11th, local time, up to now, Israel has launched more than 352 attacks in Syria, destroying military facilities in 13 provinces in Syria. On the 10th local time, the Israel Defense Forces issued a statement saying that up to now, the Israeli military has cracked down on 320 strategic targets in Syria and destroyed weapons that may fall into the hands of hostile forces. According to Israeli military estimates, more than 70% of Syria's military forces have been destroyed.Shanghai Ailu: Signed the Strategic Cooperation Agreement with Huaneng New Energy. Shanghai Ailu (301062) announced on the evening of December 11th and signed the Strategic Cooperation Agreement with Huaneng New Energy: Huaneng New Energy will combine the technological research and development and industrial introduction advantages of the company and its holding subsidiary Aina New Energy, and conduct business transactions on the "glass fiber reinforced polyurethane composite frame" products independently developed by Aina New Energy, and through product procurement and technical exchange.With the intensive IPO process of domestic semiconductor companies, we can seize new opportunities in the semiconductor chip industry through the semiconductor ETF(512480). On December 11th, the semiconductor ETF(512480) closed up 0.20% with a turnover of 1.29 billion yuan. The constituent stocks are mixed. In terms of rising, the Cambrian led the rise, and Weir shares followed. In terms of decline, Zhongwei Company led the decline, and Haiguang Information followed suit. In the news, in the fourth quarter of 2024, the IPO acceptance review in science and technology innovation board has been accelerated, with 12 companies updating their review status, mostly in the semiconductor industry. According to industry insiders, from the current audit dynamics, materials, parts and components in the upstream of the industry, as well as AI chips in the design process, may be more popular in the future. Guojin Securities pointed out that semiconductor self-control is the general trend, and it is optimistic about semiconductor equipment parts, materials and domestic computing power industry chain. CITIC Securities said that it is expected that the overall localization pace of the domestic semiconductor industry will be further accelerated, and the manufacturing sector is also expected to benefit. Investors can take advantage of the semiconductor ETF(512480) to grasp the new opportunities in the semiconductor chip industry.
With the intensive IPO process of domestic semiconductor companies, we can seize new opportunities in the semiconductor chip industry through the semiconductor ETF(512480). On December 11th, the semiconductor ETF(512480) closed up 0.20% with a turnover of 1.29 billion yuan. The constituent stocks are mixed. In terms of rising, the Cambrian led the rise, and Weir shares followed. In terms of decline, Zhongwei Company led the decline, and Haiguang Information followed suit. In the news, in the fourth quarter of 2024, the IPO acceptance review in science and technology innovation board has been accelerated, with 12 companies updating their review status, mostly in the semiconductor industry. According to industry insiders, from the current audit dynamics, materials, parts and components in the upstream of the industry, as well as AI chips in the design process, may be more popular in the future. Guojin Securities pointed out that semiconductor self-control is the general trend, and it is optimistic about semiconductor equipment parts, materials and domestic computing power industry chain. CITIC Securities said that it is expected that the overall localization pace of the domestic semiconductor industry will be further accelerated, and the manufacturing sector is also expected to benefit. Investors can take advantage of the semiconductor ETF(512480) to grasp the new opportunities in the semiconductor chip industry.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Robot concept stocks are active again and again, and Great Wheel Intelligence, Ningbo Jingda, Kelier and Keli Sensing have reached new heights.
Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.The Taiwan Affairs Office of the State Council introduced the annual meeting of the 2024 Cross-Strait Entrepreneur Summit. Zhu Fenglian, a spokesperson for the Taiwan Affairs Office, said that the 2024 Cross-Strait Entrepreneur Summit was successfully held in Xiamen, Fujian from December 9 to 10. More than 700 business people from both sides of the Taiwan Strait attended the annual summit. Focusing on the theme of "Building a new era industrial chain across the Taiwan Strait to promote cross-strait economic integration and development", they conducted in-depth discussions on issues such as promoting cross-strait industrial Internet innovation, building Taiwanese enterprises to land in their first homes, and innovating cross-strait financial service systems. The exchange atmosphere was warm, which fully demonstrated the common aspiration of cross-strait industries to strengthen exchanges and cooperation. (Riyue Tan Tian)Jizhi Co., Ltd.: Signed a supplementary agreement on development cooperation of 1.1 million yuan, and Jizhi Co., Ltd. announced that the company signed a supplementary agreement on entrusted development cooperation projects with Jiang Laboratory and Hangzhou Dilting Intelligent Technology Co., Ltd. According to the agreement, all parties have completed the development of intelligent underwater acoustic signal products, and will accelerate the application, promotion and industrialization of related products. The supplementary agreement stipulates that Jizhi shares will donate 1.1 million yuan to Zhejiang Zhijiang Development Foundation for public welfare. The signing of this agreement does not involve related party transactions, nor does it constitute a major asset restructuring. It still needs to be submitted to the company's second extraordinary shareholders meeting in 2024 for consideration. The signing of the agreement has limited impact on the company's short-term financial situation, but it is expected to have important strategic significance for the company's business development in the process of industrialization of related products.
Strategy guide
12-13
Strategy guide 12-13
Strategy guide 12-13